Anticancer and Anti-Inflammatory Properties of Chitin and Chitosan Oligosaccharides
Source abstract
Abstract
Previous reports indicate that N-acetyl-d-glucosamine oligomers (chitin oligosaccharide; NACOS) and d-glucosamine oligomers (chitosan oligosaccharide; COS) have various biological activities, especially against cancer and inflammation. In this review, we have summarized the findings of previous investigations that have focused on anticancer or anti-inflammatory properties of NACOS and COS. Moreover, we have introduced recent evaluation of NACOS and COS as functional foods against cancer and inflammatory disease.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanocomposite Films for Food Packaging · Studies on Chitinases and Chitosanases · Polysaccharides and Plant Cell Walls
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Tottori University, 4-101 Koyama-minami, Tottori 680-8553, Japan
References (63)
Show source-provided references
1. Chitin Nanostructures in Living Organisms10.1007/978-90-481-9684-5_1 ↗
2. Preparation and Biomedical Applications of Chitin and Chitosan Nanofibers10.1166/jbn.2014.1882 ↗
3. Controlled functionalization of the polysaccharide chitin10.1016/S0079-6700(01)00007-7 ↗
4. Chitin and chitosan: properties and applications10.1016/j.progpolymsci.2006.06.001 ↗
5. Chitin and chitosan polymers: Chemistry, solubility and fiber formation10.1016/j.progpolymsci.2009.04.001 ↗
6. Lodhi, G., Kim, Y.S., Hwang, J.W., Kim, S.K., Jeon, Y.J., Je, J.Y., Ahn, C.B., Moon, S.H., Jeon, B.T., and Park, P.J. (2014). Chitooligosaccharide and its derivatives: Preparation and biological applications. Biomed. Res. Int., 2014.10.1155/2014/654913 ↗
7. Preparation of chitin and chitosan oligomers and their applications in physiological functional foods10.1081/FRI-100100286 ↗
8. Applications of chitin and its derivatives in biological medicine10.3390/ijms11125152 ↗
9. Chemopreventive effect of chitosan oligosaccharide against colon carcinogenesis
10. Inhibition of proinflammatory cytokine-induced invasiveness of HT-29 cells by chitosan oligosaccharide
11. Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity10.1016/j.mehy.2009.02.018 ↗
12. Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides
13. Inhibitory effects of chitooligosaccharides on tumor growth and metastasis10.1016/j.fct.2009.04.044 ↗
14. Effect of NACOS-6 on lymphokine-activated killer cell (LAK) activity
15. Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity10.3390/ijms12010266 ↗
16. In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin10.3109/02652048.2011.621551 ↗
17. Effective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micelles10.1038/gt.2012.72 ↗
18. Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery10.1016/j.ijpharm.2012.11.018 ↗
19. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate10.3390/ijms140815755 ↗
20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy10.1016/j.ejps.2013.10.011 ↗
21. Oxidation and pH responsive nanoparticles based on ferrocene-modified chitosan oligosaccharide for 5-fluorouracil delivery10.1016/j.carbpol.2014.08.003 ↗
22. Anti-tumor properties of orally administered glucosamine and N-acetyl-d-glucosamine oligomers in a mouse model10.1016/j.carbpol.2014.04.102 ↗
23. Effect of N-acetylchitohexaose against Candida albicans infection of tumor-bearing mice10.1111/j.1348-0421.1990.tb01024.x ↗
24. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice10.1093/jn/134.4.945 ↗
25. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice10.1111/j.1349-7006.1999.tb00813.x ↗
26. Effect of low molecular weight chitosans on drug permeation through mouse skin: 1.Transdermal delivery of baicalin10.1002/jps.22063 ↗
27. Toll-like receptors are key participants in innate immune response10.4067/S0716-97602007000200001 ↗
28. Toll-like receptors: Critical proteins linking innate and acquired immunity10.1038/90609 ↗
29. TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation
30. Toll-like receptors: Lessons from knockout mice10.1042/bst0280551 ↗
31. Pathogen recognition and innate immunity10.1016/j.cell.2006.02.015 ↗
32. Therapeutic effect of a chitin oligosaccharide mixture by per os administration on human cancer10.1166/jcc.2014.1077 ↗
33. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells10.1016/j.bbrc.2007.05.042 ↗
34. Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo10.1016/j.fct.2007.09.111 ↗
35. Anti-inflammatory activity of chitooligosaccharides in vivo10.3390/md8061763 ↗
36. Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress10.1016/j.intimp.2010.10.016 ↗
37. Attenuation of pro-inflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway10.1016/j.ijbiomac.2011.06.014 ↗
38. Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE-antigen complex-stimulated RBL-2H3 cells and asthma model mice10.1016/j.intimp.2011.12.027 ↗
39. Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation10.1016/j.nutres.2012.02.004 ↗
40. Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro10.1007/s10719-012-9392-3 ↗
41. Chitosan oligosaccharides attenuate ocular inflammation in rats with experimental autoimmune anterior uveitis10.1155/2014/827847 ↗
42. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response10.1016/j.carbpol.2013.08.082 ↗
43. Chitosan oligosaccharides downregulate the expression of E-selectin and ICAM-1 induced by LPS in endothelial cells by inhibiting MAP kinase signaling10.3892/ijmm.2013.1589 ↗
44. Update in inflammatory bowel disease
45. Inflammatory bowel disease: A survey of the epidemiology in Asia10.1111/j.1751-2980.2008.00355.x ↗
46. Influence of dietary fiber on inflammatory bowel disease and colon cancer: Importance of fermentation pattern10.1111/j.1753-4887.2007.tb00282.x ↗
47. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: Therapeutic efficacy and possible mechanisms of action10.1016/j.phrs.2012.03.013 ↗
48. Anti-inflammatory effects of orally administered glucosamine oligomer in an experimental model of inflammatory bowel disease10.1016/j.carbpol.2014.09.012 ↗
49. NF-κB and the intestine: Friend or foe?10.1002/ibd.20243 ↗
50. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota10.1111/j.0105-2896.2005.00291.x ↗
51. Nitric oxide and chronic gut inflammation: Controversies in inflammatory bowel disease10.2310/6650.2002.33281 ↗
52. Cardiovascular events: A class effect by COX-2 inhibitors10.1590/S0066-782X2005001600016 ↗
53. Nitric oxide in inflammatory bowel disease10.1097/00054725-200305000-00006 ↗
54. The selective beneficial effects of nitric oxide inhibition in experimental colitis
55. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn’s disease10.1016/j.bcp.2011.06.043 ↗
56. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model10.1038/sj.bjp.0706469 ↗
57. Emerging chitin and chitosan nanofibrous materials for biomedical applications10.1039/C4NR02814G ↗
58. Safety evaluation of short-term exposure to chitooligomers from enzymic preparation10.1016/j.fct.2005.11.009 ↗
59. Advances in self-assembled chitosan nanomaterials for drug delivery10.1016/j.biotechadv.2014.07.007 ↗
60. Structures and properties of chitosan-starch-sodium benzoate blend films
61. Chitosan/polyethylene glycol blend fibers and their properties for drug controlled release10.1002/jbm.a.31544 ↗
62. Controlled release of ciprofloxacin hydrochloride from chitosan/polyethylene glycol blend films10.1016/j.carbpol.2006.10.014 ↗
63. Chitosan/starch fibers and their properties for drug controlled release10.1016/j.ejpb.2006.11.011 ↗